Incretin-based cardiovascular protection beyond diabetes: evidence, mechanisms, and therapeutic frontiers from GLP-1 receptor agonists to multi-agonist therapy

• by Libin Qiu, Jinpeng Liu, Nana Hu

• July 2, 2026

Elastography Distinguishes Cardiac Amyloidosis Types

Shear wave velocity measurements in the basal anteroseptal and right ventricular walls differed between transthyretin and light chain cardiac amyloidosis when conventional echocardiographic parameters did not.

• by Kathryn Wighton

• June 28, 2026

• 3 min

Mitochondrial DNA efflux as a potential amplifier of systemic inflammatory network rewiring in heart failure with preserved ejection fraction

• by Xingwei Zhao, Shengyu Huang, Qiulin Li, Yang Yu, Chunxiang Zhang

• June 22, 2026

Family cohesion and adaptability in heart failure: an APIMeM analysis of symptom perception and spousal caregiving on patient self-care

• by Yan Yang, Jianhua Shi, Xiaoying Gu

• June 19, 2026